Lipella Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formula…

Biotechnology
US, Pittsburgh [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Lipella Pharmaceuticals Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LIPO's Analysis
CIK: 1347242 CUSIP: 53630L100 ISIN: US53630L1008 LEI: - UEI: -
Secondary Listings
LIPO has no secondary listings inside our databases.